Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Hologic Promotions; New Hires at Insight Genetics

Premium

Hologic President and CEO John Cumming disclosed during the company's third-quarter earnings call this week that the company has promoted Rohan Hastie to the position of group vice president, and David Harding to the position of group vice president, women's health.

Hastie has served in a number of senior-level roles at Hologic, most recently as general manager of diagnostics. Previously, he had senior roles in Hologic's molecular business and corporate development group. He joined Hologic from strategic advisory firm PA Consulting, Cumming said.

Harding previously served as leader of Hologic's international team, and has also managed the company's Interventional Breast Solutions business. Prior to this, Harding served as a principal at McKinsey.


Nashville, Tenn.-based molecular diagnostics firm Insight Genetics this week announced the hiring of three employees and the promotion of another, according to a report in The Nashville Post.

David Burg has joined the company as associate director of business development. Burg will lead sales and marketing for the company's Insight Molecular Labs. Prior to joining Insight, Burg was regional sales director for Response Genetics. He has also been a senior executive oncology account manager with GlaxoSmithKline.

Insight has also hired Dan Bailey as senior associate of new product planning, and Tyler Nielsen as a research associate; and has promoted Lindsay Chatfield to the role of research associate.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.